SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
MorphoSys AG (MOR)
An SI Board Since January 2000
Posts SubjectMarks Bans
421 15 0
Emcee:  michael_f_murphy Type:  Unmoderated
Introduction Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
346 MorphoSys Unveils Next-Generation Antibody Technology Ylanthia® DecembeGermanecki-12/8/2011
345 MorphoSys and Shionogi Agree Three-Year Extension of Research Partnership NoGermanecki-12/8/2011
344 MorphoSys AG Reports Nine Months' 2011 Results October 28, 2011 / 8:00 aGermanecki-12/8/2011
343Study Shows That Roche's Investigational Drug for Alzheimer's Disease ReGermanecki-10/10/2011
342MorphoSys Reaches Second Clinical Milestone with OncoMed Pharmaceuticals April Germanecki-4/29/2011
341MorphoSys AG Reports Strong Results for the First Quarter of 2011 April 29, 2011Germanecki-4/29/2011
340MorphoSys Initiates Infectious Disease Alliance with ContraFect April 11, 2011 Germanecki-4/19/2011
339MorphoSys Signs Manufacturing Agreement with Boehringer Ingelheim March 16, 201Germanecki-4/19/2011
338Morphosys' Growth Story Remains Intact March 07, 2011 | about: IMGN / MITGermanecki-3/8/2011
337MorphoSys AG: MorphoSys to Present at Four Upcoming Investor Conferences 01.03.Germanecki-3/8/2011
336MorphoSys Announces Change in Executive Management Board Jens Holstein to succeeGermanecki-2/24/2011
335MorphoSys AG Reports Results for Fiscal Year 2010 Company Expects Revenue GrowthGermanecki-2/24/2011
334Full Installation of HuCAL Platform Triggers Double-Digit Million Euro MilestoneGermanecki-2/22/2011
333Hammer Stock Blog: Morphosys – A Biotech Rule Breaker This is not a actual analGermanecki12/19/2011
332Article on Morphosys Here is some information that might help accelerate learniDoctor Zeus22/19/2011
331I appreciate the information. No trouble understanding your English either!ghmm-2/10/2011
330Hi ghmm, my english isn't the best, but I try it. I am mot common to the beGermanecki12/10/2011
329Hi Germanecki, You seem to be pretty dedicated to the stock. I haven't folghmm-2/3/2011
32820110131 MorphoSys Reaches Clinical Milestone with Pfizer.January 31, 2011 / 7:3Germanecki-2/2/2011
32720110131 MorphoSys Reaches Clinical Milestone with OncoMed Pharmaceuticals.JanuaGermanecki-2/2/2011
32620110124 MorphoSys Announces Clinical Milestone within Boehringer Ingelheim AlliGermanecki-2/2/2011
32520110121 MorphoSys Reports Preliminary, Unaudited Financial Results for 2010 andGermanecki-2/2/2011
32412.01.2011 MorphoSys Announces Clinical Milestone from Strategic Alliance MoGermanecki-2/2/2011
32320101222 MorphoSys Reaches Seventh Clinical Milestone in 2010.December 22, 2010 Germanecki-12/22/2010
32220101210 MorphoSys Increases Revenue and Operating Profit Guidance for 2010.DeceGermanecki-12/22/2010
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News